Sanofi will offer its first batch of COVID-19 vaccine to the U.S.
Category: #health  By Saipriya Iyer  Date: 2020-05-14
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Sanofi will offer its first batch of COVID-19 vaccine to the U.S.

The company has collaborated with GlaxoSmithKline Plc to conduct this vaccine development project.

French pharmaceutical giant, Sanofi has been making tremendous advancements in COVID-19 vaccine development. Recently, the biotech made a groundbreaking announcement as it revealed that the U.S. would get its first COVID-19 vaccine, if it manages to successfully deliver one.

According to Sanofi’s Chief Executive Officer, Paul Hudson, the decision is made because the U.S. was first in line to back their company’s vaccine research. Hudson warned that Europe is at the risk of falling behind until it accelerates its efforts to combat against this devastating pandemic that has almost killed over 290,000 people across the globe.

He added that the U.S. government has earned the right to obtain the biggest batch of pre-order due to its constant support to Sanofi. The U.S. had expanded its vaccine partnership in February with the company and it expects to receive the doses first, which it had helped it manufacture.

For the record. Sanofi is one of the largest firms seeking an effective vaccine for this health crisis. It has collaborated with U.K.’s GlaxoSmithKline Plc to conduct this drug development project. In fact, the company aims to produce almost 600 million doses yearly once it successfully accomplishes this project.

Various governments have launched multiple research efforts and funding drives to develop a new vaccine for this virus. However, numerous health advocates are concerned that this race of funding could leave out those nations that aren’t able to afford protective doses, making them vulnerable to economic wreckage and mass fatalities.

In other news, Sanofi has managed to bag an approval from the U.S. Food & Drug Administration (FDA) for its sutimlimab product. Reportedly, this drug focuses on treating hemolysis in adults going through cold agglutinin disease.

Source Credit: https://theprint.in/world/us-will-get-sanofis-coronavirus-vaccine-first-if-the-drug-giants-efforts-succeed/421000/



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

 Tabletop Tape Dispensers  market valuation to surge at healthy CAGR through 2026

Tabletop Tape Dispensers market valuation to surge at healthy CAGR through 2026

By Saipriya Iyer

A comprehensive research study on Tabletop Tape Dispensers market added by Market Study Report provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Tabletop Tape D...

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

By Saipriya Iyer

MarketStudyReport.com presents latest report on global General Well-Being Dietary Supplements Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The re...

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

By Saipriya Iyer

The report Eugenia Jambolana Extract market provides high-quality information regarding the major market trends, product types and their application scope, competitive landscape, and impact of COVID-19 outbreak.

.

Request a...